 a Data include safety follow-up using the safety analysis set from the safety population and exclude hypoglycemia episodes occurring after initiation of new antihyperglycemic therapy. Events per patient-year of exposure are presented as group mean. b Severe hypoglycemia was defined as an episode with severe cognitive impairment requiring the assistance of another person to actively administer carbohydrate, glucagon, or other resuscitative actions. Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes Original Investigation Research jama.com (Reprinted) JAMA November 7, 2023 Volume 330, Number 17 1639 Â© 2023 American Medical Association. All rights reserved. Downloaded from jamanetwork.com by F. Hoffmann - La Roche LTD user on 10/02/2024schemes, and drug delivery devices. Second, use of the standardized insulin algorithm and blood glucose tar- gets may not be generalizable to participants outside of the trial setting. Third, this trial was not designed to discon- tinue insulin therapy. Fourth, patients using sodium- glucose cotransporter-2 inhibitors were excluded from this study. Conclusions Inpeoplewithinadequatelycontrolledtype2diabetestreated with basal insulin, weekly tirzepatide compared with pran- dialinsulinasanadd-ontoinsulinglarginedemonstratedre- ductionsinHbA1c andbodyweightwithlesshypoglycemia.